Intra-arterial therapy (IAT) for acute ischemic stroke has undergone great evolution during the past decade. While intra-venous therapy remains the standard of care for eligible patients, there are those patients in whom IV tPA is contraindicated, or those who fail to improve following IV tPA. In those cases, patients with accessible arterial occlusions may benefit from IAT, especially when rec...

Figure 1. Total WBC count (0) and ANC (e) for patient 1, a 37year-old male who developed vancomycin-induced neutropenia. G-CSF (600 f.Lg iv) was initially administered on days 30 and 33 of therapy. Additional 300-f.Lg doses of iv G-CSF were administered twice weekly (on days 38-52) and thrice weekly (on days 55-78) until vancomycin therapy was completed. ANC = absolute neutrophil count. 8,500

Objective: The aim of this study is to retrospectively collect the data 95 patients with ischemic stroke who received intravenous (IV) tissue plasminogen activator (tPA) therapy between 2015 and 2019 in our clinic, present experiences clinic. 
 Method: patients, applied clinic diagnosis acute 2019, thrombolytic therapy, were reviewed retrospectively. General socio-demographic data, clinica...

Patients with progressive hepatic form of GSD IV often die of liver failure in early childhood. We tested the feasibility of using recombinant human acid-α glucosidase (rhGAA) for treating GSD IV. Weekly intravenously injection of rhGAA at 40 mg/kg for 4 weeks significantly reduced hepatic glycogen accumulation, lowered liver/body weight ratio, and reduced plasma ALP and ALT activities in GSD I...

nephritis remains an important problem in patients with systemic lupus erythematosus (sle). we conducted retrospective study to evaluate the efficiency of intravenous pulse cyclophosphamide in lupus nephritis: from 1983 to 1993, we reviewed 133 patients with biopsy proven lupus nephritis, 47 of them excluded because of short period of follow-up or defective laboratory data. eighty six patients ...

Heart failure is a progressive clinical syndrome that results in structural or functional abnormalities of the heart disrupt heart’s performance pumping blood. The manifestations are shortness breath and cardiomegaly. purpose study was to determine Lisinopril therapy (dose, route administration, frequency) patients at hospitalized installation Sidoarjo Hospital. method collecting data retrospec...

BACKGROUND AND PURPOSE The objective of this study was to determine the clinical features, angiographic findings, and response to treatment with thrombolytic therapy in patients with ischemic stroke caused by acute occlusion of the distal internal carotid artery. METHODS This is a retrospective case series from a prospectively collected stroke database for patients with acute internal carotid...